Role of francisella lipid A phosphate modification in virulence and long-term protective immune responses

Infection and Immunity

Volumn 80, Issue 3, 2012, Pages 943-951

  Kanistanon, Duangjit ^a,b   Powell, Daniel A ^b   Hajjar, Adeline M ^c   Pelletier, Mark R ^b   Cohen, Ilana E ^c   Way, Sing Sing ^e   Skerrett, Shawn J ^d   Wang, Xiaoyuan ^f   Raetz, Christian R H ^g   Ernst, Robert K ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f JIANGNAN UNIVERSITY   (China)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; GLUCOSAMINE DERIVATIVE; INTERLEUKIN 8; LIPID A; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHATASE; PHOSPHATE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; B LYMPHOCYTE; BACTERIAL CLEARANCE; BACTERIAL IMMUNITY; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CARBOHYDRATE ANALYSIS; CELL DIVISION; CELLULAR IMMUNITY; CHEMICAL MODIFICATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; FRANCISELLA; FRANCISELLA NOVICIDA; HOST; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; LIVER; MACROPHAGE; MOUSE; MUTANT; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PRIMARY INFECTION; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION; SPLEEN; STATIC ELECTRICITY; SUBCUTANEOUS TISSUE; SURVIVAL RATE; T LYMPHOCYTE;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FRANCISELLA; GENE KNOCKOUT TECHNIQUES; GRAM-NEGATIVE BACTERIAL INFECTIONS; IMMUNITY, INNATE; LIPID A; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHATES; PHOSPHORIC MONOESTER HYDROLASES; RECEPTORS, IMMUNOLOGIC; SURVIVAL ANALYSIS; VIRULENCE;

EID: 84863264702     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06109-11     Document Type: Article

References (35)

1. Ahlund MK, Ryden P, Sjostedt A, Stoven S. 2010. Directed screen of Francisella novicida virulence determinants using Drosophila melanogaster. Infect. Immun. 78:3118-3128.
2. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499-511.
3. Anthony LS, Morrissey PJ, Nano FE. 1992. Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism. J. Immunol. 148:1829-1834.
4. Brandenburg K, Wiese A. 2004. Endotoxins: relationships between structure, function, and activity. Curr. Top. Med. Chem. 4:1127-1146.
5. Butchar JP, Parsa KV, Marsh CB, Tridandapani S. 2008. IFNγ enhances IL-23 production during Francisella infection of human monocytes. FEBS Lett. 582:1044-1048.
6. Cole LE, et al. 2006. Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity. J. Immunol. 176:6888-6899.
7. Cole LE, et al. 2009. Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge. Proc. Natl. Acad. Sci. U. S. A. 106:4343-4348.
8. De Pascalis R, Taylor BC, Elkins KL. 2008. Diverse myeloid and lymphoid cell subpopulations produce gamma interferon during early innate immune responses to Francisella tularensis live vaccine strain. Infect. Immun. 76:4311-4321.
9. Duckett NS, Olmos S, Durrant DM, Metzger DW. 2005. Intranasal interleukin-12 treatment for protection against respiratory infection with the Francisella tularensis live vaccine strain. Infect. Immun. 73:2306-2311.
10. El Hamidi A, Tirsoaga A, Novikov A, Hussein A, Caroff M. 2005. Microextraction of bacterial lipid A: easy and rapid method for mass spectrometric characterization. J. Lipid Res. 46:1773-1778.
11. Ernst RK, et al. 1999. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286:1561-1565.
12. Fernandes-Alnemri T, et al. 2010. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat. Immunol. 11:385-393.
13. Greenberger MJ, et al. 1996. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J. Infect. Dis. 173:159-165.
14. Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI. 2002. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3:354-359.
15. Hajjar AM, et al. 2006. Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect. Immun. 74:6730-6738.
16. - infection in gene-targeted immunodeficient mice: major role of CD4+ TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. J. Immunol. 156:3321-3326.
17. Kanistanon D, et al. 2008. A Francisella mutant in lipid A carbohydrate modification elicits protective immunity. PLoS Pathog. 4:e24.
18. Keim P, Johansson A, Wagner DM. 2007. Molecular epidemiology, evolution, and ecology of Francisella. Ann. N. Y. Acad. Sci. 1105:30-66.
19. Lauriano CM, et al. 2004. MglA regulates transcription of virulence factors necessary for Francisella tularensis intraamoebae and intramacrophage survival. Proc. Natl. Acad. Sci. U. S. A. 101:4246-4249.
20. Li H, Nookala S, Bina XR, Bina JE, Re F. 2006. Innate immune response to Francisella tularensis is mediated by TLR2 and caspase-1 activation. J. Leukocyte Biol. 80:766-773.
21. LoVullo ED, Sherrill LA, and Pavelka MS, Jr. 2009. Improved shuttle vectors for Francisella tularensis genetics. FEMS Microbiol. Lett. 291:95-102.
22. Malik M, et al. 2006. Toll-like receptor 2 is required for control of pulmonary infection with Francisella tularensis. Infect. Immun. 74:3657-3662.
23. McLendon MK, Apicella MA, Allen LA. 2006. Francisella tularensis: taxonomy, genetics, and Immunopathogenesis of a potential agent of biowarfare. Annu. Rev. Microbiol. 60:167-185.
24. Miller SI, Ernst RK, Bader MW. 2005. LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 3:36-46.
25. Mohapatra NP, et al. 2008. Combined deletion of four Francisella novicida acid phosphatases attenuates virulence and macrophage vacuolar escape. Infect. Immun. 76:3690-3699.
26. Pammit MA, Raulie EK, Lauriano CM, Klose KE, Arulanandam BP. 2006. Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia. Infect. Immun. 74:2063-2071.
27. Parsa KV, et al. 2008. Francisella gains a survival advantage within mononuclear phagocytes by suppressing the host IFNγ response. Mol. Immunol. 45:3428-3437.
28. Partida-Sanchez S, et al. 2001. Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo. Nat. Med. 7:1209-1216.
29. Raetz CR, Reynolds CM, Trent MS, Bishop RE. 2007. Lipid A modification systems in gram-negative bacteria. Annu. Rev. Biochem. 76:295-329.
30. Raetz CR, Whitfield C. 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71:635-700.
31. Sjostedt A. 2007. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann. N. Y. Acad. Sci. 1105:1-29.
32. Somerville JE, Jr, Cassiano L, Bainbridge B, Cunningham MD, Darveau RP. 1996. A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J. Clin. Invest. 97:359-365.
33. Takaoka A, Yanai H. 2006. Interferon signalling network in innate defence. Cell Microbiol. 8:907-922.
34. Trent MS, Stead CM, Tran AX, Hankins JV. 2006. Diversity of endotoxin and its impact on pathogenesis. J. Endotoxin Res. 12:205-223.
35. Wang X, Ribeiro AA, Guan Z, Abraham SN, Raetz CR. 2007. Attenuated virulence of a Francisella mutant lacking the lipid A 4'-phosphatase. Proc. Natl. Acad. Sci. U. S. A. 104:4136-4141.